ArticleFrontiers in neuroscience2025
Endocannabinoid-mediated regulation of depression in the ovBNST.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeting Pain and Depression in Alzheimer's Disease: Translational Insights and Emerging Treatments.Pharmaceuticals (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The bed nucleus of stria terminalis (BNST) acts as a crucial hub for assessing vigilant threats, with the oval subnucleus (ovBNST) being enriched in endocannabinoid ligands and receptors. The endocannabinoid system (ECS) is well recognized for its role in stress responses. However, the molecular and circuitry mechanisms through which the ovBNST ECS mediates chronic stress induced depressive phenotypes remain unclear. Methods and results: The chronic unpredictable mild stress (CUMS) was optimized to model the depression-like behaviors and body weight loss in mice. By utilizing the endocannabinoid sensor, an increased release of endocannabinoid in the ovBNST was probed in response to acute stress. Local blockage of ovBNST cannabinoid type 1 receptor (CB1R) with NESS0327 induced both anhedonia and despair depressive phenotypes in naïve mice. In contrast, intra-ovBNST infusion of either CB1R agonist or cannabinoid hydrolase inhibitor JZL-184 ameliorated despair-like behaviors while merely changed anhedonia in CUMS mice. By combining viral tracing with RNAscope and western blotting, the reduction in CB1R transcriptional and translational level was found to be associated with the CUMS induced depressive disorders. This reduction may be attributed to the changes in ovBNST located presynaptic CB1R that originates from the medial prefrontal cortex (mPFC). Discussion: Overall, these results suggest that chronic stress may restructure the ovBNST ECS to result in depressive phenotypes. This study may extend the comprehension of ECS in the ovBNST, specifically its role in modulating the pathogenesis of depressive disorders induced by chronic stress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.